Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immune Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT01821781
What this trial is testing

Immune Disorder HSCT Protocol

Who this might be right for
Immune Deficiency DisordersSevere Combined ImmunodeficiencyChronic Granulomatous Disease+11 more
Washington University School of Medicine 20
Post-approval studies (Phase 4)Study completedNCT00335686
What this trial is testing

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 67
Early research (Phase 1)Study completedNCT00001112
What this trial is testing

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableEnrolling By InvitationNCT00895271
What this trial is testing

Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

Who this might be right for
Primary ImmunodeficiencyDOCK8Virus Susceptibility
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT03919695
What this trial is testing

Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda

Who this might be right for
Alcohol Use DisorderHIV-infection/Aids
San Diego State University 160
Testing effectiveness (Phase 2)Study completedNCT00002227
What this trial is testing

Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Dupont Merck 60
Large-scale testing (Phase 3)Study completedNCT00002230
What this trial is testing

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Who this might be right for
HIV Infections
Northwestern University 100
Not applicableUnknownNCT04172181
What this trial is testing

Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID

Who this might be right for
Severe Combined Immunodeficiency Disease
Children's Hospital of Fudan University 50
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00158457
What this trial is testing

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 40
Testing effectiveness (Phase 2)Study completedNCT00105157
What this trial is testing

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 179
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Large-scale testing (Phase 3)UnknownNCT00004981
What this trial is testing

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Who this might be right for
HIV Infections
Glaxo Wellcome 230
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Testing effectiveness (Phase 2)Study completedNCT00243230
What this trial is testing

Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 116
Testing effectiveness (Phase 2)Study completedNCT00551330
What this trial is testing

Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 111
Post-approval studies (Phase 4)UnknownNCT02404233
What this trial is testing

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects

Who this might be right for
HIV Positive
Therapeutic Concepts 30
Testing effectiveness (Phase 2)Study completedNCT00002240
What this trial is testing

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Next Page